Established in 2008, Visirna Biotechnology (Shanghai) provides one-stop comprehensive services ranging from early-stage structure-based drug development to commercial drug production for global innovative drug research and development companies. It has built several advanced technology platforms, including X-ray protein crystal technology, Cryo-EM, ASMS, SPR, HDX-MS, and computer-assisted drug design. Through its subsidiary, Langhua Pharmaceutical, Visirna provides a one-stop CMC/CDMO solution from preclinical development to commercial production. Additionally, Visirna focuses on discovering and investing in high-potential bio-pharmaceutical startups, employing a unique business model of Equity-for-Service (EFS) to address unmet clinical needs.

Disease Domain	Count

Endocrinology and Metabolic Disease	2

Top 5 Drug Type	Count

siRNA	3

Top 5 Target	Count

ANGPTL3(Angiopoietin like 3)	1
17β-HSD13(17-beta-hydroxysteroid dehydrogenase 13)	1
APOC3(Apolipoprotein C-III)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2

Current Projects

Drug(Targets)	Indications	Global Highest Phase

VSA-006 ( 17β-HSD13 )	Nonalcoholic Steatohepatitis More	Phase 2
Plozasiran ( APOC3 )	Hypertriglyceridemia More	Phase 2
VSA-003 ( ANGPTL3 )	Dyslipidemias More	Phase 2

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis